Center Book Partners LP Illumina, Inc. Transaction History

Center Book Partners LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$127.73 - $147.2 $6.9 Million - $7.95 Million	54,024 Added 76.82%	124,352 $17.1 Million
Q4 2023 Feb 13, 2024	BUY	$92.79 - $142.53 $4.16 Million - $6.4 Million	44,883 Added 176.39%	70,328 $9.79 Million
Q3 2023 Nov 13, 2023	BUY	$128.91 - $192.44 $516,800 - $771,491	4,009 Added 18.7%	25,445 $3.49 Million
Q2 2023 Aug 14, 2023	SELL	$183.43 - $232.67 $126,016 - $159,844	-687 Reduced 3.11%	21,436 $4.02 Million
Q1 2023 May 15, 2023	BUY	$193.75 - $232.55 $3.3 Million - $3.96 Million	17,049 Added 336.01%	22,123 $5.14 Million
Q4 2022 Feb 13, 2023	BUY	$187.24 - $242.74 $311,941 - $404,404	1,666 Added 48.88%	5,074 $1.03 Million
Q3 2022 Nov 14, 2022	SELL	$177.23 - $227.44 $54,586 - $70,051	-308 Reduced 8.29%	3,408 $650,000
Q2 2022 Aug 15, 2022	BUY	$181.58 - $368.0 $270,191 - $547,584	1,488 Added 66.79%	3,716 $685,000
Q1 2022 May 16, 2022	BUY	$303.87 - $423.8 $289,891 - $404,305	954 Added 74.88%	2,228 $778,000
Q4 2021 Feb 11, 2022	BUY	$347.28 - $421.83 $442,434 - $537,411	1,274 New	1,274 $485,000

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Center Book Partners LP, based on Form 13F filings with the SEC.

Stay updated on Center Book Partners LP with notifications on news.